Multivalent nanoparticles activate T-dependent antibody response via antigen presentation by both B cells and dendritic cells
Xuejing Ma(Institute of Biophysics), Baidong Hou(University of Chinese Academy of Sciences), Keyan Bao(Chinese Academy of Sciences), Runhan Li(Chinese Academy of Sciences), Zhiyu Gao(Sichuan University), Xueli Zhang(Chinese Academy of Sciences), George F. Gao(Chinese Academy of Sciences), Penghui Ma(PLA Electronic Engineering Institute), Chang Guo(Chinese Academy of Sciences), Han Wang(Peking University), Ping Zhu(Institute of Biophysics), Mingzhao Zhu(Chinese Academy of Sciences), Wenjun Wang(Chinese Academy of Sciences), Zhaolin Hua(Institute of Biophysics)
Cited by 0
Related Papers
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
|Cell|2022|538
Engineering central metabolic modules of Escherichia coli for improving β-carotene production
|Metabolic Engineering|2013|331
Metabolic engineering of Saccharomyces cerevisiae for production of ginsenosides
|Metabolic Engineering|2013|237
Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B
|Nature Nanotechnology|2020|234
Metabolic evolution of two reducing equivalent-conserving pathways for high-yield succinate production in Escherichia coli
|Metabolic Engineering|2014|134